DEVELOPMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the field of biopharmaceuticals, featuring promising progress across several health-related and industrial apps. With its structural similarity to naturally derived human serum albumin, OsrHSA supplies a safer, extra trusted substitute for therapeutic use, specifical